Cargando…
High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returne...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136353/ https://www.ncbi.nlm.nih.gov/pubmed/30203719 http://dx.doi.org/10.1080/16549716.2018.1500763 |
_version_ | 1783354982007832576 |
---|---|
author | Yang, Zhiqi Zhou, Changming Ning, Zhu Lu, Wei Zhao, Qi Hu, Yi Diwan, Vinod K. Xu, Biao |
author_facet | Yang, Zhiqi Zhou, Changming Ning, Zhu Lu, Wei Zhao, Qi Hu, Yi Diwan, Vinod K. Xu, Biao |
author_sort | Yang, Zhiqi |
collection | PubMed |
description | Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returned patients, and smear-positive patients at the end of the third month of initial treatment. Objective: To estimate the possibility of detecting MDR-TB cases if only the high-risk screening strategy is applied in China. Methods: A secondary analysis was applied to the surveillance-based longitudinal data of all sputum smear-positive TB patients in Prefecture E and Prefecture W of China from 2013 to 2015. The population attributable risk (PAR) was estimated using odds ratios for five risk factors/predictors and exposure proportions amongst all MDR-TB cases. Results: A total of 3513 TB patients (2807 from Prefecture E and 706 from Prefecture W) were included. Males accounted for 77.91% (2737/3513) of the patients. The average age was 52.5 ± 20.0 years old. Overall, 40.34% (71/176) of MDR-TB patients were from the five high-risk groups during the three-year study period. The detected proportion of MDR-TB cases using the high-risk screening strategy was significantly higher in Prefecture E than in Prefecture W. The PAR% for all five risk factors/predictors was 43.4% (95% CI: 24.6–61.7%), 49.9% (95% CI: 31.3–67.0%), and 30.3% (95% CI: 12.9–50.1%) in Prefecture E and 36.6% (95% CI: 10.4–64.5%), 13.3% (95% CI: −1.7–39.7%), and −82.5% (95% CI: −117.5–−11.2%) in Prefecture W in 2013, 2014, and 2015, respectively. The PAR% for the five specific risk factors/predictors ranged from 0.4% (95% CI: −0.2–4.8%) to 21.0% (95% CI: 13.1–30.0%) in these two prefectures. Conclusion: In general, a high-risk screening strategy would miss more than half of the MDR-TB patients because they do not belong to the five high-risk groups. |
format | Online Article Text |
id | pubmed-6136353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-61363532018-09-14 High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis Yang, Zhiqi Zhou, Changming Ning, Zhu Lu, Wei Zhao, Qi Hu, Yi Diwan, Vinod K. Xu, Biao Glob Health Action Original Article Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returned patients, and smear-positive patients at the end of the third month of initial treatment. Objective: To estimate the possibility of detecting MDR-TB cases if only the high-risk screening strategy is applied in China. Methods: A secondary analysis was applied to the surveillance-based longitudinal data of all sputum smear-positive TB patients in Prefecture E and Prefecture W of China from 2013 to 2015. The population attributable risk (PAR) was estimated using odds ratios for five risk factors/predictors and exposure proportions amongst all MDR-TB cases. Results: A total of 3513 TB patients (2807 from Prefecture E and 706 from Prefecture W) were included. Males accounted for 77.91% (2737/3513) of the patients. The average age was 52.5 ± 20.0 years old. Overall, 40.34% (71/176) of MDR-TB patients were from the five high-risk groups during the three-year study period. The detected proportion of MDR-TB cases using the high-risk screening strategy was significantly higher in Prefecture E than in Prefecture W. The PAR% for all five risk factors/predictors was 43.4% (95% CI: 24.6–61.7%), 49.9% (95% CI: 31.3–67.0%), and 30.3% (95% CI: 12.9–50.1%) in Prefecture E and 36.6% (95% CI: 10.4–64.5%), 13.3% (95% CI: −1.7–39.7%), and −82.5% (95% CI: −117.5–−11.2%) in Prefecture W in 2013, 2014, and 2015, respectively. The PAR% for the five specific risk factors/predictors ranged from 0.4% (95% CI: −0.2–4.8%) to 21.0% (95% CI: 13.1–30.0%) in these two prefectures. Conclusion: In general, a high-risk screening strategy would miss more than half of the MDR-TB patients because they do not belong to the five high-risk groups. Taylor & Francis 2018-09-11 /pmc/articles/PMC6136353/ /pubmed/30203719 http://dx.doi.org/10.1080/16549716.2018.1500763 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yang, Zhiqi Zhou, Changming Ning, Zhu Lu, Wei Zhao, Qi Hu, Yi Diwan, Vinod K. Xu, Biao High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title | High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title_full | High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title_fullStr | High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title_full_unstemmed | High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title_short | High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis |
title_sort | high-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of china: a drug susceptibility surveillance-based secondary data analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136353/ https://www.ncbi.nlm.nih.gov/pubmed/30203719 http://dx.doi.org/10.1080/16549716.2018.1500763 |
work_keys_str_mv | AT yangzhiqi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT zhouchangming highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT ningzhu highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT luwei highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT zhaoqi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT huyi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT diwanvinodk highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis AT xubiao highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis |